Edge Therapeutics

Latest Headlines

Latest Headlines

Edge Therapeutics hauls in $72.5M for brain injury R&D

New Jersey biotech Edge Therapeutics pocketed $72.5 million in a series of funding rounds, piling up cash as it prepares to take its lead treatment for brain injuries into Phase III development.

AstraZeneca welcomes Soriot as new CEO; O'Day and Diggelmann move up within Roche

Welcome to this week's roundup of hirings and firings throughout the industry. Please send the good word (or the bad) from your shop to Alison Bryant (email | Twitter) and Nesa Nourmohammadi (...

Edge picks MPI to test 3 brain injury treatments

MPI Research and Edge Therapeutics have partnered to conduct trials toward the testing of products they hope can combat the effects of brain hemorrhage.